Sole Source Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – West (HCD-W), intends to award a firm fixed-price purchase order on a sole source basis to Illumina, Inc. for Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits (UPIP). This procurement is for the Department of Clinical Investigation (DCI) at Tripler Army Medical Center, Hawaii. Capability statements challenging this sole source intent are due by April 22, 2026.
Scope of Work
This requirement is for the procurement of one (1) Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kit (UPIP). These kits are essential for the DCI at Tripler Army Medical Center and are specifically designed for compatibility with the Government-owned MiSeq Systems.
Contract & Timeline
- Type: Notice of Intent to Award a Sole Source Supply Contract (Firm Fixed-Price Purchase Order)
- Awardee (Intended): Illumina, Inc.
- Delivery Date: September 1, 2026
- Delivery Location: Tripler Army Medical Center, Department of Clinical Investigation, 1 Jarrett White Road, Bldg 40, Tripler AMC, HI 96859-5000
- NAICS: 541714 (Research and Technology in Biotechnology, except Nanobiotechnology); Size Standard: 1,000 employees
- PSC: 6550 (Medical Equipment and Accessories and Supplies)
- Published: April 14, 2026
Evaluation & Submission
This is not a request for competitive proposals. The Government intends to proceed with a sole source award to Illumina, Inc., citing that Illumina is the only source capable of meeting the minimum requirements due to the proprietary nature of their sequencing supplies for the Government's MiSeq Systems. There is no reasonable expectation of receiving quotes from two or more small businesses.
Sources interested in challenging this sole source intent must submit a capability statement demonstrating their ability to provide the required equipment and preventive maintenance. Statements must include management, technical data, and cost information, not exceeding six (8.5 x 11 inch) pages with a font size no smaller than 10-point.
Response Details
- Capability Statements Due: No later than 1000 Pacific Daylight Time, Wednesday, April 22, 2026.
- Submission Email: bobbie.s.dobberstein.ctr@health.mil (Bobbie Dobberstein)
- Format: Microsoft Word or Adobe PDF attachment.
- Note: No telephone requests or offers will be honored. A determination not to compete is at the Government's discretion.